|
Epidemiology of Surfactant Protein-B Deficiency Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Epidemiology of Surfactant Protein-B Deficiency conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Epidemiology of Surfactant Protein-B Deficiency Clinical research trials and Epidemiology of Surfactant Protein-B Deficiency medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Epidemiology of Surfactant Protein-B Deficiency. Epidemiology of Surfactant Protein-B Deficiency Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Epidemiology of Surfactant Protein-B Deficiency clinical trial. Subjects often receive the most expert healthcare possible for their Epidemiology of Surfactant Protein-B Deficiency condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Epidemiology of Surfactant Protein-B Deficiency  Epidemiology of Surfactant Protein-B Deficiency
Epidemiology of Surfactant Protein-B Deficiency
For Condition: Respiratory Distress Syndrome,Lung Diseases
Status: Not yet recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To determine the impact of surfactant protein B genetic mutations on the risk of respiratory distress syndrome in infancy.
Details: BACKGROUND: Respiratory distress syndrome (RDS) is a common cause of death and morbidity in infants in the United States; approximately 1,300 die annually with this diagnosis. Understanding the underlying mechanisms that lead to RDS is crucial for improving outcomes and reducing health care costs associated with RDS. Dr. Cole and his colleagues were the first to identify a gene mutation in the pulmonary surfactant B gene (121ins2) as a cause of RDS. The alteration produces a truncated, unstable transcript but no protein is synthesized. More recently this group used the Missouri linked birth-death database and the New York birth cohort to estimate 121ins2 allele frequency. Approximately 1 per 1-3,000 individuals carry the mutation; the mutant gene appears to be codominant at the molecular level (heterozygotes express subnormal levels of surfactant B), but recessive at the clinical level. No known clinical phenotype exists for heterozygotes. The study should lead to identification of clinically useful markers of genetic risk and more rational design of treatment for lethal as well as non-lethal RDS. DESIGN NARRATIVE: The descriptive and case-control population-based studies focus on clinically significant mutations in the surfactant protein B gene and estimation of the frequency of the 121ins2 mutation in ethnically and geographically distinct populations. Dr. Cole and colleagues have described the first clinical syndrome of inherited pulmonary surfactant deficiency due to a specific mutation (12lins2) in the surfactant protein B gene that causes respiratory distress immediately after birth and is lethal within the first six months of life. To identify mutations and assess mutation frequency, the group will use denaturing high performance liquid chromatography separation of duplexed amplicons from DNA extracted from 20,000 blood spots from infants in a single, annual Missouri birth cohort and automated sequencing of heteroduplexes. To determine the clinical phenotype of infants with identified mutations, they will use identifiers from the Missouri birth-death certificate database linked to each blood spot to retrieve individual medical records for chart review. To determine whether identified mutations result in lower surfactant protein B concentrations in tracheal effluent, they will perform a case-control study of approximately 1800 infants from metropolitan St. Louis with clinically significant respiratory distress syndrome. Finally, they will estimate ethnic frequency of the 121ins2 mutation using molecular amplification and restriction enzyme digestion of DNA extracted from blood spots of infants in an Asian population (Seoul, South Korea), a Black and White African population (Cape Town, South Africa), a western European population (Oslo, Norway), and compare these to an admixed American population (Missouri).
Eligibility:
Study Type: Observational, Natural History, Case Control
Minimum Age/Maximum Age: /1 Year
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
F.Cole, , Washington University School of Medicine
Additional Information:
Study ID Numbers: 967;
Study Start Date: June 2001
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00014859
Other Lung Diseases Studies:
1. Sleep Apnea in Elderly Male Twins
2. Idiopathic Pulmonary Fibrosis: a Case-control Study
3. Inhaled NO for the Prevention of Chronic Lung Disease
4. Lymphangioleiomyomatosis (LAM) Registry
5. Tuberculosis Prophylaxis in the Homeless--A Controlled Trial
Related Studies:
Other Lung Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Epidemiology of Surfactant Protein-B Deficiency
|
|
|
|
|
|
|
|
